Decentralized Clinical Trials: Implementation of a Hybrid Model from a Site and Sponsor Perspective

Life Sciences, Clinical Trials, Patient Recruitment & Retention, Drug Discovery & Development,
  • Thursday, December 02, 2021

Running Decentralized Clinical Trials (DCTs) is a new and complex challenge for most of the stakeholders within the pharmaceutical industry. There are a lot of theoretical discussions and multiple approaches to conducting DCTs, but it’s most useful to see how they are implemented from a real operational perspective. What is the impact on the Patients? What is their perspective? Is it possible to create a simple, effective and feasible approach to DCTs?

This webinar will focus on discussing the flexible tools necessary for adapting work to a number of different clinical trial models, including site-based, hybrid and virtual trials.

The speakers will each share insights on DCTs from their unique areas of expertise: the operational point of view, the Patient perspective and an eye to the future from a sponsor company.

Key questions to be answered will include:

  • What are the challenges of DCTs for sites and sponsors?
  • What are the new roles for sites and PIs (e.g., Patient oversight, assistance and home visits)?
  • How can staff better meet the needs of Patients through DCTs (e.g., improving access to trials, Patient journey and retention)?
  • How will DCTs change the collaboration between sponsors, PIs and sites?

Register for this webinar to learn how to solve some of the most common challenges of running Decentralized Clinical Trials to ensure the needs of Patients, sites and sponsors are met.

Speakers

Dr. Ole Dammann, CEO, kfgn I Site Operations & Services; Board Member, Country Head Germany, Pratia S.A.

Dr. Ole Dammann is the country head for Germany and board member of Pratia S.A. At Pratia, he is also involved in the digitization of clinical research and the development of new business models. Ole is engaged in several projects in digital healthcare. They focus on the validation of digital health apps as well as diagnostic solutions. He has a deep understanding of clinical research and the clinical research market. Before joining kfgn, Ole worked in various positions in the chemical and healthcare industry with the latest positions in finance. He holds a master’s degree in business (Dipl.-Kfm.) and a Ph.D. in Organization from the University of Mannheim with a research stay at Stanford University.

Message Presenter

Karl-Ludwig Radek, Internal Project Lead for IMI [email protected], The Janssen Pharmaceutical Companies of Johnson & Johnson

Karl is an economist by training and certified financial advisor. After several years working in the public healthcare sector in Germany, he joined J&J in Germany in 2015. Although he has no direct clinical operations background, one of his key strengths is to see things differently. In his current role, he is responsible for establishing and managing relations with site networks across Europe, the Middle East and Africa. In addition, he is also the Janssen project lead for the IMI project [email protected] In 2020/2021 he was also a member of the European Health Parliament – a group of next-generation healthcare leaders that is developing healthcare policies for better healthcare provision in Europe.

Message Presenter
http://Michał%20Kwiatek

Michał Kwiatek, MD, PhD, Investigator, Site Director, Pratia S.A.

Michał is a hematologist who specializes in lymphoproliferative diseases. Medical director of the PRATIA POZNAŃ clinical research center, as well as a co-founder of two medical start-ups: BADANIA.pl and NEO-INSIGHT.

Message Presenter

Who Should Attend?

Professionals in Decentralized / Remote / Virtual Trials, with relevant job titles including:

  • Head of Clinical Innovation
  • Digital Strategy Lead Clinical Trial Innovation
  • Head/Director Clinical Operations
  • Global Clinical Development – Country Head
  • Chief Clinical Development Officer
  • Clinical Research Director
  • Principal Investigator
  • Medical Director
  • Site Manager Lead
  • Patient Engagement
  • Advocacy Lead

What You Will Learn

Key questions to be answered will include:

  • What are the challenges of DCTs for sites and sponsors?
  • What are the new roles for sites and PIs (e.g., Patient oversight, assistance and home visits)?
  • How can staff better meet the needs of Patients through DCTs (e.g., improving access to trials, Patient journey and retention)?
  • How will DCTs change the collaboration between sponsors, PIs and sites?

Xtalks Partner

Pratia

Pratia is a platform for innovative medicine which offers the best mix of sites, expertise and access to patients for each protocol, as well as close collaboration with the local healthcare systems. We are a research organization platform that brings tech-savvy, adaptable solutions for innovative treatments at your convenience. With 90+ centers across 6 countries in Europe, and 700+ Clinical Trials carried out since 2012, we strive to connect patients & professionals via our platform in order to create better access to innovative care. We can conduct studies within 30+ therapeutical areas at the convenience of our patients, partners, and physicians. We can address the dynamically changing requirements in the industry, including remote monitoring and decentralized studies.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account